DS
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Extrafollicular CD19lowCXCR5−CD11c− double negative 3 (DN3) B cells are significantly associated with disease activity in females with systemic lupus erythematosus | Journal of translational autoimmunity | 2024 | 10 | 7 | |||
Diagnostic et étiologie de l’insuffisance surrénalienne primaire | Revue médicale suisse | 2024 | 18 | 0 | |||
Detection of TPSAB1 copy number variation for the diagnosis of hereditary alpha-tryptasemia by quantitative PCR | Clinical & experimental allergy | 2024 | 39 | 0 | |||
Value of biologic markers in the field of allergic disease: what is the role of laboratory medicine in recent and future years? | 2022 | 198 | 0 | ||||
Atypical pulmonary phaeohyphomycosis due to Aureobasidium spp. - case report and brief literature review | Swiss medical weekly | 2022 | 137 | 29 | |||
Nouveaux outils dans les hypersensibilités alimentaires : par-delà les prick tests et IgE spécifiques | Revue médicale suisse | 2021 | 78 | 34 | |||
Patients with elevated basal tryptase serum levels should be tested for hereditary alpha-tryptasemia | European Annals of Allergy and Clinical Immunology | 2021 | 199 | 436 | |||
Prevalence of large vessel vasculitis in ANCA-associated vasculitis: a retrospective cohort study | Rheumatology international | 2021 | 141 | 54 | |||
Three cases of BRAF mutation negative Erdheim-Chester disease with a challenging distinction from IgG4-related disease | Allergy, Asthma, and Clinical Immunology | 2021 | 458 | 106 | |||
Antinuclear Antibodies With a Homogeneous and Speckled Immunofluorescence Pattern Are Associated With Lack of Cancer While Those With a Nucleolar Pattern With the Presence of Cancer | Frontiers in Medicine | 2020 | 317 | 251 | |||
Allergologie-immunologie - Prise en charge de l'artérite gigantocellulaire en 2019 | Revue médicale suisse | 2020 | 444 | 60 | |||
Specific IgE Decision Point Cutoffs in Children with IgE-Mediated Wheat Allergy and a Review of the Literature | International Archives of Allergy and Immunology | 2020 | 246 | 0 | |||
Long-term Remission of Wells Syndrome With Omalizumab | Journal of Investigational Allergology & Clinical Immunology | 2020 | 198 | 1 | |||
Identifying True Celiac Disease and Wheat Allergy in the Era of Fashion Driven Gluten-Free Diets | International Archives of Allergy and Immunology | 2019 | 214 | 0 | |||
Are antibodies against La (SSB) no longer useful for the diagnosis of Sjögren's syndrome? | Clinical and Experimental Rheumatology | 2019 | 213 | 1 | |||
Présentation des nouveaux algorithmes de dosage d'ANCA | Revue médicale suisse | 2019 | 269 | 124 | |||
Anaphylactic shock to H1 antihistamine drug bilastine: A case report | The Journal of Allergy and Clinical Immunology: In Practice | 2018 | 371 | 3 | |||
Le livedo : physiopathologie et diagnostic | Revue médicale suisse | 2018 | 273 | 2 | |||
Immune Checkpoint Inhibitor-Associated Myocarditis: A New Challenge for Cardiologists | Canadian Journal of Cardiology | 2018 | 482 | 2 | |||
Hypersensitivity to an intracerebral stent and symptomatic cerebral lesions: A possible link? | Journal of Dermatology | 2017 | 343 | 0 | |||
Anaphylactic shock following castor bean contact: a case report | Allergy, Asthma, and Clinical Immunology | 2017 | 404 | 184 | |||
Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"? | International Journal of Molecular Sciences | 2017 | 410 | 201 | |||
Syndrome DRESS (drug reaction with eosinophilia and systemic symptoms) | Revue médicale suisse | 2016 | 346 | 0 | |||
Non-IgE-Dependent Hypersensitivity to Rocuronium Reversed by Sugammadex: Report of Three Cases and Hypothesis on the Underlying Mechanism | International archives of allergy and immunology | 2016 | 444 | 1 | |||
Pitfalls and peculiarities in chlorhexidine allergy | The Journal of Allergy and Clinical Immunology: In Practice | 2016 | 382 | 166 | |||
Allergologie : Omalizumab dans le traitement de l'urticaire chronique : quoi de neuf en 2013 ? | Revue médicale suisse | 2014 | 548 | 1 |